Jinzhou Guo

National Clinical Research Center of Kidney Diseases

H指数:6

被引数:143

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The early dFLC level after autologous stem cell transplantation can predict the long-term prognosis of in patients with light chain amyloidosis

自体干细胞移植后早期dFLC水平可预测轻链淀粉样变性患者的长期预后

Annals of Hematology

IF2.4

2026-08-110

Long-term outcomes of autologous stem cell transplantation for AL amyloidosis: a 15-year experience from a Chinese referral center and a comparison of different eras

自体干细胞移植治疗AL淀粉样变的长期结局：一项来自中国转诊中心的15年经验及不同时期的比较

Blood Cancer Journal

IF11.6

2026-03-090

OAAI

Bortezomib combined with autologous stem cell transplantation overcomes cytogenetic abnormalities in AL amyloidosis

硼替佐米联合自体干细胞移植克服了AL淀粉样变性中的细胞遗传学异常

International Journal of Hematology

IF1.8

2025-12-010

PRE

The pre-ASCT serum albumin and pre-ASCT dFLC are prognostic markers in renal light chain amyloidosis patients treated with autologous stem cell transplantation

自体干细胞移植治疗的肾轻链淀粉样变性患者的术前ASCT血清白蛋白和术前ASCT dFLC是预后标志物。

BONE MARROW TRANSPLANTATION

IF5.2

2025-04-010

PRE

Clinical Manifestations and Prognosis of Chronic Kidney Disease after Hematopoietic Stem Cell Transplantation

造血干细胞移植后慢性肾脏病的临床表现与预后

KIDNEY DISEASES

IF3.1

2025-03-120

Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance

自体造血干细胞移植治疗非AL型淀粉样变性肾意义单克隆 gammopathy

NEPHROLOGY DIALYSIS TRANSPLANTATION

IF5.6

2025-02-190

PRE

Serum free light chain level-based and non-fixed cycle daratumumab treatment strategy for patients with light chain amyloidosis

ANNALS OF MEDICINE

IF4.3

2024-12-190

OAAI

Association of B cells and the risk of Esophageal cancer: a bidirectional two-sample mendelian randomization study

BMC CANCER

IF3.4

2024-11-160

OAAI

Treg cells as a protective factor for Hashimoto`s thyroiditis: a Mendelian randomization study

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-03-081

OAAI

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis

FRONTIERS IN ONCOLOGY

IF3.3

2023-05-031

OAAI

Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal Involvement

伴有肾脏受累的轻链淀粉样变性自体干细胞移植后植入综合征的特征

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2023-02-012

OAAI

The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvement

ANNALS OF MEDICINE

IF4.3

2022-04-284

OAAI

The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patients

低疾病负担AL淀粉样变性患者自体干细胞移植前诱导治疗的作用

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

IF7.4

2020-10-2110

PREAI

Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis

自体造血干细胞移植治疗难治性狼疮性肾炎

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2019-04-1225

OAAI

Combination of bortezomib in the induction, conditioning and consolidation with autologous hematopoietic stem cell transplantation in patients with immunoglobulin light chain amyloidosis

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2019-02-044

OAAI

Jinzhou Guo

个人简介

教育背景

工作经历

荣誉奖项

研究方向